The traditional approach to drug discovery has remained largely unchanged for decades—slow, manual, and expensive. However, advancements in automation and technology are beginning to reshape the landscape. Arctoris, a leader in this transformation, is revolutionising the field by combining cutting-edge robotics with structural biology and protein sciences to accelerate the discovery process.

The company’s fully automated Ulysses platform allows for rapid testing of thousands of compounds, akin to searching for the perfect key to unlock a complex mechanism. By automating this traditionally labour-intensive process, Arctoris is driving faster, more reliable results. The integration of AI and advanced data analytics also enables the processing of vast amounts of data, making it possible to identify previously hidden patterns. This innovative approach is not only increasing the efficiency of drug discovery but also bringing us closer to finding cures for the world’s most challenging diseases.